APA (7th ed.) Citation

Liu, Y., Gong, L., Feng, J., Xiao, C., Liu, C., Chen, B., . . . Huang, W. (2025). Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity. Journal of nanobiotechnology, 23(1), 194-22. https://doi.org/10.1186/s12951-025-03170-y

Chicago Style (17th ed.) Citation

Liu, Yanhong, et al. "Co-delivery of Axitinib and PD-L1 SiRNA for the Synergism of Vascular Normalization and Immune Checkpoint Inhibition to Boost Anticancer Immunity." Journal of Nanobiotechnology 23, no. 1 (2025): 194-22. https://doi.org/10.1186/s12951-025-03170-y.

MLA (9th ed.) Citation

Liu, Yanhong, et al. "Co-delivery of Axitinib and PD-L1 SiRNA for the Synergism of Vascular Normalization and Immune Checkpoint Inhibition to Boost Anticancer Immunity." Journal of Nanobiotechnology, vol. 23, no. 1, 2025, pp. 194-22, https://doi.org/10.1186/s12951-025-03170-y.